Showing results (1121-1130 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|March 10, 2006
Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoeaCharles D EricssonDrug Safety|March 10, 2006
Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profileJörg T Hartmann, Hans-Peter LippDrug Safety|March 10, 2006
Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosisLaurent Uzan, Laurence Guignat, Christophe Meune, et al.Drug Safety|July 1, 1991
Prevention and management of drug-induced peripheral neuropathyL L Olesen, T S JensenDrug Safety|April 22, 2008
Drug-induced urinary retention: incidence, management and preventionKatia M C Verhamme, Miriam C J M Sturkenboom, Bruno H Ch Stricker, et al.Drug Safety|April 22, 2008
The European Herbal Medicines Directive: could it have saved the lives of Romeo and Juliet?Philip A RoutledgeDrug Safety|April 22, 2008
European legislation on herbal medicines: a look into the futureGioacchino CalapaiDrug Safety|April 22, 2008
Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilanceLidia SautebinDrug Safety|April 22, 2008
Assessment of the risk of fragrance allergy in the general population: challenges and methodological issuesLuigi NaldiDrug Safety|February 6, 1999
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patientsN Principi, S EspositoPageof 311